These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36724882)

  • 1. De novo metabolic syndrome after liver transplantation: a meta-analysis on cumulative incidence, risk factors, and outcomes.
    Lim WH; Tan C; Xiao J; Tan DJH; Ng CH; Yong JN; Fu C; Chan KE; Zeng RW; Ren YP; Goh XL; Chew N; Tseng M; Syn N; Mak LY; Fung J; Muthiah M; Siddiqui MS; Tan EXX
    Liver Transpl; 2023 Apr; 29(4):413-421. PubMed ID: 36724882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcome?
    Herreras López J; Puchades L; Di Maira T; Cañada AJ; Maupoey J; López-Andújar R; Prieto Castillo M; Berenguer Haym M; Aguilera V
    Rev Esp Enferm Dig; 2022 Oct; 114(10):586-591. PubMed ID: 35045717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
    Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
    Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation.
    Becchetti C; Ferrarese A; Zeni N; Russo FP; Senzolo M; Gambato M; Bassi D; Cillo U; Burra P; Germani G
    Clin Transplant; 2022 Feb; 36(2):e14532. PubMed ID: 34757678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained Posttransplantation Diabetes Is Associated With Long-Term Major Cardiovascular Events Following Liver Transplantation.
    Roccaro GA; Goldberg DS; Hwang WT; Judy R; Thomasson A; Kimmel SE; Forde KA; Lewis JD; Yang YX
    Am J Transplant; 2018 Jan; 18(1):207-215. PubMed ID: 28640504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.
    De Luca L; Kalafateli M; Bianchi S; Alasaker N; Buzzetti E; Rodríguez-Perálvarez M; Thorburn D; O'Beirne J; Patch D; Leandro G; Westbrook R; Tsochatzis EA
    Liver Int; 2019 Aug; 39(8):1557-1565. PubMed ID: 31233663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
    Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
    Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis after liver transplantation: a systematic review and meta-analysis.
    Silva AC; Nogueira P; Machado MV
    Liver Transpl; 2023 Apr; 29(4):431-448. PubMed ID: 36735478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.
    Laish I; Braun M; Mor E; Sulkes J; Harif Y; Ben Ari Z
    Liver Transpl; 2011 Jan; 17(1):15-22. PubMed ID: 21254340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death.
    Hu LS; Chai YC; Zheng J; Shi JH; Zhang C; Tian M; Lv Y; Wang B; Jia A
    World J Gastroenterol; 2018 Nov; 24(43):4920-4927. PubMed ID: 30487701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes.
    Grupper A; Rabinowich A; Ben Shabat I; Tzadok R; Schwartz D; Schwartz IF; Goykhman Y; Kliuk Ben-Bassat O; Baruch R; Shashar M; Cohen-Hagai K; Katchman H
    Am J Nephrol; 2022; 53(8-9):636-645. PubMed ID: 36075195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients.
    Gitto S; de Maria N; di Benedetto F; Tarantino G; Serra V; Maroni L; Cescon M; Pinna AD; Schepis F; Andreone P; Villa E
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):766-773. PubMed ID: 29505475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for metabolic syndrome after liver transplantation: A systematic review and meta-analysis.
    Thoefner LB; Rostved AA; Pommergaard HC; Rasmussen A
    Transplant Rev (Orlando); 2018 Jan; 32(1):69-77. PubMed ID: 28501338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
    Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
    Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and Metabolic Consequences of Liver Transplantation: A Review.
    Plotogea O; Ilie M; Sandru V; Chiotoroiu A; Bratu O; Diaconu C
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pretransplant Diabetes on Outcomes After Liver Transplantation: An Updated Meta-analysis With Systematic Review.
    Tang ASP; Tan C; Lim WH; Ng CH; Tan DJH; Zeng R; Xiao J; Ong EYH; Cho E; Chung C; Lim WS; Chee D; Nah B; Tseng M; Syn N; Bonney G; Liu K; Huang DQ; Muthiah M; Siddiqui MS; Tan EXX
    Transplantation; 2024 May; 108(5):1157-1165. PubMed ID: 37899382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.